user

Optimizing lysosomal activation of antibody-drug conjugates (ADCs) by incorporation of novel cleavable dipeptide linkers

被引：0
|
作者：
Salomon, Paulin [1 ]
Harris, Luke [1 ]
Reid, Emily E. [1 ]
Maloney, Erin K. [1 ]
Wilhelm, Alan J. [1 ]
Miller, Michael L. [1 ]
Chari, Ravi V. [1 ]
Keating, Thomas A. [1 ]
Singh, Rajeeva [1 ]
机构：
[1] ImmunoGen Inc, Waltham, MA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-231
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
231
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Overcoming limitations of current Antibody-Drug Conjugates (ADCs) by a novel linker technology
    Spycher, Philipp Rene
    Frei, Julia Carina
    Wehrmueller, Jori Elias
    Attinger-Toller, Isabella
    Grabulovski, Dragan
    Hechler, Torsten
    Kulke, Michael
    Pahl, Andreas
    Behe, Martin
    Schibli, Roger
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [22] Chemically Cleavable Antibody-Drug Conjugates: Drug Release in One Click
    de Geus, M. A. R.
    ten Hoeve, W.
    Hudson, P.
    Janssen, H. M.
    Khasanov, A.
    van Onzen, A. H. A. M.
    Robillard, M. S.
    Rossin, R.
    Steenbergen, E. J.
    Versteegen, R. M.
    Wessels, H. J.
    Wu, J.
    [J]. SYNLETT, 2018, 29 (18) : A180 - A184
  • [23] The critical role of cleavable linkers for minor groove binding alkylating agent (MGBA) based antibody-drug conjugates
    Gangwar, Ssnjeev
    Pan, Chin
    Zhang, Qian
    Rao, Chetana
    Sufi, Bilal
    Green, Lynae
    Passmore, David
    Huber, Mary
    Chong, Collin
    Kwok, Eilene
    Cortez, Orville
    Passmore, Peter
    Chen, Liang
    Gueriavais, Vincent
    Rangan, Vangiouram
    Deshpande, Shrikant
    Cardarelli, Pina
    King, David
    Terrett, Jon
    [J]. CANCER RESEARCH, 2009, 69
  • [24] A dual-enzyme cleavable linker for antibody-drug conjugates
    Bargh, Jonathan D.
    Walsh, Stephen J.
    Ashman, Nicola
    Isidro-Llobet, Albert
    Carroll, Jason S.
    Spring, David R.
    [J]. CHEMICAL COMMUNICATIONS, 2021, 57 (28) : 3457 - 3460
  • [25] Optimizing the potential of antibody-drug conjugates in oncology
    Mosele, F.
    Montagnac, G.
    Pistilli, B.
    Andre, F.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 (11) : 964 - 967
  • [26] Antibody-conjugated drug assay for protease-cleavable antibody-drug conjugates
    Sanderson, Russell J.
    Nicholas, Nicole D.
    Lee, Cassandra Baker
    Hengel, Shawna Mae
    Lyon, Robert P.
    Benjamin, Dennis R.
    Alley, Stephen C.
    [J]. BIOANALYSIS, 2016, 8 (01) : 55 - 63
  • [27] Development and properties of β-glucuronide linkers for monoclonal antibody-drug conjugates
    Jeffrey, SC
    Andreyka, JB
    Bernhardt, SX
    Kissler, KM
    Kline, T
    Lenox, JS
    Moser, RF
    Nguyen, MT
    Okeley, NM
    Stone, IJ
    Zhang, XQ
    Senter, PD
    [J]. BIOCONJUGATE CHEMISTRY, 2006, 17 (03) : 831 - 840
  • [28] Development of novel antibody-drug conjugates
    Takahashi, Shunji
    [J]. CANCER SCIENCE, 2021, 112 : 1026 - 1026
  • [29] Toward a Ferrous Iron-Cleavable Linker for Antibody-Drug Conjugates
    Spangler, Benjamin
    Kline, Toni
    Hanson, Jeffrey
    Li, Xiaofan
    Zhou, Sihong
    Wells, James A.
    Sato, Aaron K.
    Renslo, Adam R.
    [J]. MOLECULAR PHARMACEUTICS, 2018, 15 (05) : 2054 - 2059
  • [30] Drug-Linkers in Antibody-Drug Conjugates: Perspective on Current Industry Practices
    Bulger, Paul G.
    Conlon, David A.
    Cink, Russell D.
    Fernandez-Cerezo, Lara
    Zhang, Qunying
    Thirumalairajan, Srinath
    Raglione, Thomas
    Liang, Ruiting
    Zhou, Jinsheng
    Chalgeri, Arun
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, 27 (07) : 1248 - 1257
12345